naphthalene-1,5-dimaleimide has been researched along with Glioma in 1 studies
*Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bracci, P; Christensen, BC; Clarke, J; Hansen, H; Kelsey, KT; Koestler, DC; McCoy, L; Molinaro, AM; Nissen, E; Rice, T; Salas, LA; Tamaki, CM; Tamaki, SJ; Tang, E; Taylor, JW; Warrier, G; Wiencke, JK; Wrensch, M; Zhang, Z | 1 |
1 other study(ies) available for naphthalene-1,5-dimaleimide and Glioma
| Article | Year |
|---|---|
DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival.
Topics: Biomarkers; Dexamethasone; DNA Methylation; Glioma; Glucocorticoids; Humans; Maleimides; Prednisone | 2022 |